Hansa Biopharma AB (publ) (HNSBF) Short Interest Ratio & Short Volume $2.74 0.00 (0.00%) As of 08/22/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Hansa Biopharma AB (publ) Short Interest DataHansa Biopharma AB (publ) (HNSBF) has a short interest of 635,300 shares. This marks a -12.42% decrease in short interest from the previous month. The short interest ratio (days to cover) is 529.4, indicating that it would take 529.4 days of the average trading volume of 1,800 shares to cover all short positions.Current Short Interest635,300 sharesPrevious Short Interest725,400 sharesChange Vs. Previous Month-12.42%Dollar Volume Sold Short$1.74 millionShort Interest Ratio529.4 Days to CoverLast Record DateJuly 31, 2025Today's Trading Volume0 sharesAverage Trading Volume1,800 sharesToday's Volume Vs. Average0% Short Selling Hansa Biopharma AB (publ)? Sign up to receive the latest short interest report for Hansa Biopharma AB (publ) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHNSBF Short Interest Over TimeHNSBF Days to Cover Over TimeHNSBF Percentage of Float Shorted Over Time Hansa Biopharma AB (publ) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025635,300 shares $1.74 million -12.4%N/A529.4 $2.74 7/15/2025725,400 shares $2.18 million -2.4%N/A0 $3.00 6/30/2025742,900 shares $2.23 million +0.2%N/A0 $3.00 6/15/2025741,300 shares $2.22 million +3.6%N/A0 $3.00 5/31/2025715,300 shares $2.15 million +1.1%N/A0 $3.00 5/15/2025707,600 shares $2.12 million +9.1%N/A78.6 $3.00 4/30/2025648,600 shares $1.95 million No ChangeN/A0 $3.00 4/15/2025648,600 shares $1.95 million No ChangeN/A0 $3.00 3/31/2025648,600 shares $1.95 million -0.6%N/A0 $3.00 3/15/2025652,300 shares $1.96 million +0.9%N/A0 $3.00 Get the Latest News and Ratings for HNSBF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hansa Biopharma AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025646,700 shares $1.94 million +0.8%N/A0 $3.00 2/15/2025641,700 shares $1.93 million +95.8%N/A0 $3.00 1/31/2025327,700 shares $983.10 thousand -39.8%N/A0 $3.00 1/15/2025544,600 shares $1.63 million +2.0%N/A5446 $3.00 12/31/2024534,000 shares $1.60 million -1.3%N/A890 $3.00 12/15/2024541,000 shares $1.53 million No ChangeN/A1352.5 $2.83 11/30/2024541,000 shares $1.97 million No ChangeN/A0 $3.65 11/15/2024541,000 shares $1.97 million No ChangeN/A0 $3.65 10/31/2024541,000 shares $1.97 million -0.3%N/A5410 $3.65 10/15/2024542,400 shares $1.59 million No ChangeN/A0 $2.93 9/30/2024542,400 shares $1.59 million +0.3%N/A0 $2.93 9/15/2024541,000 shares $1.59 million -1.0%N/A0 $2.93 8/31/2024546,600 shares $1.60 million +1.7%N/A0 $2.93 8/15/2024537,500 shares $1.57 million +10.9%N/A0 $2.93 7/31/2024484,500 shares $1.42 million -0.9%N/A1615 $2.93 7/15/2024489,000 shares $1.43 million -2.2%N/A0 $2.93 6/30/2024499,900 shares $1.46 million -6.5%N/A0 $2.93 6/15/2024534,700 shares $1.57 million -2.7%N/A0 $2.93 5/31/2024549,700 shares $1.61 million -4.8%N/A0 $2.93 5/15/2024577,600 shares $1.69 million No ChangeN/A0 $2.93 4/30/2024577,600 shares $1.69 million -2.1%N/A0 $2.93 4/15/2024590,200 shares $1.73 million +0.7%N/A0 $2.93 3/31/2024586,300 shares $1.72 million -1.8%N/A0 $2.93 3/15/2024596,900 shares $1.94 million +4.4%N/A746.1 $3.26 2/29/2024571,500 shares $1.86 million -0.2%N/A0 $3.26 2/15/2024572,600 shares $1.86 million +7.7%N/A2863 $3.26 1/15/2024451,800 shares $1.20 million -0.6%N/A4518 $2.65 12/31/2023454,600 shares $1.03 million -0.4%N/A235.2 $2.26 12/15/2023456,200 shares $1.37 million -0.2%N/A0 $3.00 11/30/2023457,000 shares $1.37 million +3.0%N/A0 $3.00A New Way to Double Your Retirement Income? (Ad)Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.Click here to see how to turn your savings into a monthly income machine. 11/15/2023443,500 shares $1.33 million -2.4%N/A0 $3.00 10/31/2023454,500 shares $1.36 million -15.7%N/A0 $3.00 10/15/2023538,800 shares $1.62 million -0.2%N/A5388 $3.00 9/30/2023539,800 shares $2.12 million -0.5%N/A0 $3.93 9/15/2023542,500 shares $2.13 million No ChangeN/A5425 $3.93 8/31/2023542,500 shares $2.13 million +0.4%N/A1629 $3.93 8/15/2023540,200 shares $2.57 million +0.4%N/A0 $4.76 7/31/2023538,300 shares $2.85 million +1.6%N/A2691.5 $5.30 7/15/2023530,100 shares $2.81 million +3.2%N/A0 $5.30 6/30/2023513,600 shares $2.72 million -0.1%N/A0 $5.30 6/15/2023514,200 shares $2.72 million -0.1%N/A0 $5.30 5/31/2023514,700 shares $2.73 million -0.4%N/A0 $5.30 5/15/2023517,000 shares $2.74 million -0.4%N/A574.4 $5.30 4/30/2023519,100 shares $2.70 million +0.2%N/A0 $5.20 4/15/2023517,900 shares $2.69 million -0.3%N/A0 $5.20 3/31/2023519,200 shares $2.70 million +3.3%N/A0 $5.20 3/15/2023502,600 shares $2.61 million -11.4%N/A5026 $5.20 2/28/2023567,000 shares $2.95 million +2.8%N/A0 $5.20 2/15/2023551,600 shares $2.87 million +16.0%N/A2758 $5.20 1/31/2023475,700 shares $3.14 million -0.9%N/A528.6 $6.60 1/15/2023480,000 shares $2.40 million +9.5%N/A1600 $5.01 12/30/2022438,400 shares $2.16 million -8.8%N/A0 $4.93 12/15/2022480,700 shares $2.37 million +2.0%N/A4807 $4.93 11/30/2022471,200 shares $2.27 million +2.7%N/A0 $4.82 11/15/2022458,700 shares $2.21 million +6.5%N/A655.3 $4.82 10/31/2022430,800 shares $2.48 million +0.5%N/A0 $5.75 10/15/2022428,500 shares $2.46 million -10.8%N/A0 $5.75 9/30/2022480,200 shares $2.76 million +7.9%N/A0 $5.75 9/15/2022445,000 shares $2.56 million +20.5%N/A4450 $5.75 8/31/2022369,400 shares $2.09 million +12.0%N/A284.2 $5.66 8/15/2022329,800 shares $1.87 million -22.2%N/A0 $5.66 7/31/2022424,000 shares $2.40 million +26.9%N/A0 $5.66 7/15/2022334,100 shares $1.89 million -18.6%N/A0 $5.66 6/30/2022410,600 shares $2.32 million -12.3%N/A0 $5.66 6/15/2022467,900 shares $2.65 million -10.6%N/A0 $5.66 5/31/2022523,400 shares $2.96 million -5.4%N/A0 $5.66 5/15/2022553,200 shares $3.13 million -0.7%N/A1383 $5.66 4/30/2022557,000 shares $3.25 million -0.2%N/A5570 $5.84 4/15/2022557,900 shares $3.96 million +0.6%N/A5579 $7.10 3/31/2022554,600 shares $5.13 million +7.9%N/A0 $9.25 3/15/2022513,900 shares $4.75 million -9.6%N/A0 $9.25 2/28/2022568,200 shares $5.26 million +7.4%N/A0 $9.25 2/15/2022528,900 shares $4.89 million +26.7%N/A5289 $9.25 1/31/2022417,400 shares $3.86 million +43.8%N/A0 $9.25 1/15/2022290,300 shares $2.69 million +180.5%N/A725.8 $9.25 12/31/2021103,500 shares $1.05 million -1.1%N/A0 $10.10 12/15/2021104,600 shares $1.06 million -10.0%N/A209.2 $10.10 11/30/2021116,200 shares $2.11 million +10.9%N/A0 $18.20 11/15/2021104,800 shares $1.91 million +0.3%N/A0 $18.20 10/29/2021104,500 shares $1.90 million -5.4%N/A0 $18.20A New Way to Double Your Retirement Income? (Ad)Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.Click here to see how to turn your savings into a monthly income machine. 10/15/2021110,500 shares $2.01 million +0.1%N/A0 $18.20 9/30/2021110,400 shares $2.01 million +1.9%N/A0 $18.20 9/15/2021108,400 shares $1.97 million -27.4%N/A0 $18.20 8/31/2021149,200 shares $2.72 million -2.6%N/A0 $18.20 8/13/2021153,100 shares $2.79 million -23.6%N/A0 $18.20 7/30/2021200,400 shares $3.65 million -16.7%N/A0 $18.20 7/15/2021240,500 shares $4.38 million -9.0%N/A0 $18.20 6/30/2021264,200 shares $4.81 million +33.1%N/A1321 $18.20 6/15/2021198,500 shares $3.25 million -38.7%N/A0 $16.40 5/28/2021323,800 shares $5.31 million +3.4%N/A129.5 $16.40 5/14/2021313,200 shares $5.32 million -8.2%N/A0 $16.99 4/30/2021341,300 shares $5.80 million -13.2%N/A0 $16.99 4/15/2021393,200 shares $6.68 million +18.0%N/A0 $16.99 3/31/2021333,300 shares $5.66 million +15.9%N/A833.3 $16.99 3/15/2021287,500 shares $8.48 million -12.3%N/A0 $29.50 2/26/2021327,800 shares $9.67 million No ChangeN/A0 $29.50 2/12/2021327,800 shares $9.67 million -2.8%N/A0 $29.50 1/29/2021337,200 shares $9.95 million -25.2%N/A3372 $29.50 1/15/2021341,300 shares $10.07 million +107.4%N/A0 $29.50 12/31/2020342,900 shares $10.12 million +0.5%N/A0 $29.50 12/15/2020341,300 shares $10.07 million +107.4%N/A0 $29.50 11/30/2020164,600 shares $4.86 million +207.7%N/A0 $29.50 11/15/202053,500 shares $1.58 million +25.9%N/A535 $29.50 10/30/202042,500 shares $1.19 million -12.9%N/A0 $28.03 10/15/202048,800 shares $1.37 million +0.4%N/A25.7 $28.03 9/30/202048,600 shares $1.32 million -0.2%N/A486 $27.14 9/15/202048,700 shares $1.32 million +0.2%N/A0 $27.14 8/31/202048,600 shares $1.32 million +0.2%N/A0 $27.14 HNSBF Short Interest - Frequently Asked Questions What is Hansa Biopharma AB (publ)'s current short interest? Short interest is the volume of Hansa Biopharma AB (publ) shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 635,300 shares of HNSBF short. Learn More on Hansa Biopharma AB (publ)'s current short interest. What is a good short interest ratio for Hansa Biopharma AB (publ)? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HNSBF shares currently have a short interest ratio of 529.0. Learn More on Hansa Biopharma AB (publ)'s short interest ratio. Is Hansa Biopharma AB (publ)'s short interest increasing or decreasing? Hansa Biopharma AB (publ) saw a decrease in short interest during the month of July. As of July 31st, there was short interest totaling 635,300 shares, a decrease of 12.4% from the previous total of 725,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Hansa Biopharma AB (publ) stock? Short selling HNSBF is an investing strategy that aims to generate trading profit from Hansa Biopharma AB (publ) as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hansa Biopharma AB (publ)? A short squeeze for Hansa Biopharma AB (publ) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HNSBF, which in turn drives the price of the stock up even further. How often is Hansa Biopharma AB (publ)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HNSBF, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies 3SBio Short Interest Data Algernon Pharmaceuticals Short Interest Data ALK-Abelló A/S Short Interest Data Apollomics Short Interest Data Ascentage Pharma Group International Short Interest Data Ascletis Pharma Short Interest Data Avacta Group Short Interest Data Awakn Life Sciences Short Interest Data AXIM Biotechnologies Short Interest Data BriaCell Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HNSBF) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hansa Biopharma AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Hansa Biopharma AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access